Back to search results

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

Abroad (travel likely)Recruiting

Conditions

Prostate Cancer · Prostate Adenocarcinoma · Prostate Cancer Metastatic · Castration-resistant Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Dana Rathkopf, MD) · rathkopd@MSKCC.ORG · 646-422-4428
    Contact: Study coordinator (Rachel Breitman, RN) · breitmar@mskcc.org · 908-542-3190

  • Duke University Medical Center, Durham, North Carolina, United States

    Contact: Study coordinator (Julia Hurrelbrink, RN, BSN) · julia.hurrelbrink@duke.edu · 919-681-1030
    Contact: Principal Investigator (Andrew Armstrong, MD, ScM)

  • University of Wisconsin-Madison, Madison, Wisconsin, United States

    Contact: Study coordinator (Laura Ruelle) · laura.ruelle@wisc.edu · 608-890-4800
    Contact: Principal Investigator (Joshua Lang, MD)
Study leads

  • Andrew Armstrong, MD

    Principal Investigator

    Duke University

View source on ClinicalTrials.gov(opens in a new tab)